Skip to main content
Erschienen in:

05.01.2022

Examining Psychological and Knowledge Barriers to Colorectal Cancer Screening in Rural Appalachian Kentucky

verfasst von: Caroline R. Jenkins, Matthew Rutledge, Lauren Hudson, Nathan L. Vanderford, Nancy E. Schoenberg

Erschienen in: Journal of Cancer Education | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

While recent rates of colorectal cancer (CRC) screening have improved in Appalachian Kentucky due to public health efforts, they remain lower compared to both KY as a whole, and the USA. Suboptimal screening rates represent a missed opportunity to engage in early detection and prevention. The purpose of this study is to determine the impact that lack of knowledge has on psychological barriers (e.g., fear and embarrassment) to CRC screening as well as the potential effect of a psychosocial intervention to reduce these barriers. Participants were recruited through faith-based organizations and other community sites. After randomizing participants to either an early or delayed group, a faith-based group education and motivational interviewing intervention was administered. Existing and pilot tested instruments were used to assess knowledge and potential psychological barriers. Data were analyzed using paired t tests and linear regression. We hypothesized that (1) psychological barriers are associated with inadequate knowledge and (2) the intervention, by improving knowledge, could reduce these barriers and increase screening rates. There was a small but significant reduction in psychological barriers (−0.11, p value = 0.015) and moderate increases in CRC knowledge scores (+0.17, p value = 0.06). There was no evidence that the intervention affected these measures (+0.10, p value = 0.58). The relationship between lower barrier scores and increased knowledge was significant at follow up (−0.05, 95% CI (−0.09, −0.00)). An increase in CRC knowledge was correlated with a small but significant decrease in psychological barriers, although there was no evidence that these changes were associated with one another. Future cognitive-based interventions may be effective in increasing CRC knowledge and reducing barriers, but new intervention approaches should be considered.
Literatur
2.
Zurück zum Zitat Cavallo J. Stemming the growing cancer crisis in rural Appalachia. 2017 Cavallo J. Stemming the growing cancer crisis in rural Appalachia. 2017
4.
Zurück zum Zitat Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P (2015) Challenges of rural cancer care in the United States. Oncology (Williston Park). 29(9):633–640 Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P (2015) Challenges of rural cancer care in the United States. Oncology (Williston Park). 29(9):633–640
5.
Zurück zum Zitat Crosby R, Wendel M, Vanderpool R, Casey B (2012) Rural populations and health: determinants, disparities, and solutions. John Wiley & Sons Crosby R, Wendel M, Vanderpool R, Casey B (2012) Rural populations and health: determinants, disparities, and solutions. John Wiley & Sons
14.
Zurück zum Zitat Mulat B, Boroda K, Hertan H 1673 Multitarget Stool DNA Test (Cologuard™): a double-edged sword. Official Journal of the American College of Gastroenterology | ACG. 2019;114 Mulat B, Boroda K, Hertan H 1673 Multitarget Stool DNA Test (Cologuard™): a double-edged sword. Official Journal of the American College of Gastroenterology | ACG. 2019;114
20.
Zurück zum Zitat Vanderpool RC, Huang B, Deng Y, Bear TM, Chen Q, Johnson MF et al (2019) Cancer-related beliefs and perceptions in Appalachia: findings from 3 states. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association. 35(2):176–188. https://doi.org/10.1111/jrh.12359CrossRef Vanderpool RC, Huang B, Deng Y, Bear TM, Chen Q, Johnson MF et al (2019) Cancer-related beliefs and perceptions in Appalachia: findings from 3 states. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association. 35(2):176–188. https://​doi.​org/​10.​1111/​jrh.​12359CrossRef
29.
Zurück zum Zitat Roland KB, Milliken EL, Rohan EA, DeGroff A, White S, Melillo S et al (2017) Use of community health workers and patient navigators to improve cancer outcomes among patients served by federally qualified health centers: a systematic literature review. Health Equity. 1(1):61–76. https://doi.org/10.1089/heq.2017.0001CrossRef Roland KB, Milliken EL, Rohan EA, DeGroff A, White S, Melillo S et al (2017) Use of community health workers and patient navigators to improve cancer outcomes among patients served by federally qualified health centers: a systematic literature review. Health Equity. 1(1):61–76. https://​doi.​org/​10.​1089/​heq.​2017.​0001CrossRef
30.
Zurück zum Zitat Bertakis KD, Azari R, Helms JL, Callahan EJ, Robbins JA (2000) Gender differences in the utilization of health care services. The Journal of Family Practice. 49(2):147–152 Bertakis KD, Azari R, Helms JL, Callahan EJ, Robbins JA (2000) Gender differences in the utilization of health care services. The Journal of Family Practice. 49(2):147–152
31.
Zurück zum Zitat Smyth J, Webb M (2020) Oikawa m. Self-report of cancer-related behaviors. Smyth J, Webb M (2020) Oikawa m. Self-report of cancer-related behaviors.
Metadaten
Titel
Examining Psychological and Knowledge Barriers to Colorectal Cancer Screening in Rural Appalachian Kentucky
verfasst von
Caroline R. Jenkins
Matthew Rutledge
Lauren Hudson
Nathan L. Vanderford
Nancy E. Schoenberg
Publikationsdatum
05.01.2022
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 1/2023
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-021-02120-0

Neu im Fachgebiet Onkologie

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.